Fig. 2
From: Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer
The serum CPT1A levels from healthy controls, patients with benign breast diseases and breast cancer. a Serum CPT1A levels in the training set. b Serum CPT1A levels in the test set. c Serum CPT1A levels in the whole set. The horizontal lines indicated median values. Statistical significance was determined by the Mann–Whitney U test. **p < 0.001, ***p < 0.0001